BioCer Entwicklungs-GmbH is a young and innovative medical device company from Bayreuth, Bavaria. We specialize in research, development and production of innovative medical biomaterial products without animal or human components. As a service provider on behalf of our customers, we offer innovative coating systems for existing implant systems and develop new medical products.
BioCer Entwicklungs-GmbH commercializes innovative technologies developed in conjunction with leading national and international Universities. BioCer´s primary technology is the development and production of plant based haemostatic materials, to assist medical professionals in the control of blood loss in a diverse range of complex surgical procedures. BioCer have also commercialized a unique advanced surface coating system of Titanium Oxide, to optimize the biocompatibility of surgical mesh for application in hernia repair and breast reconstruction.
HaemoCer™ Absorbable Polysaccharide Haemostat (APH) is a proprietary patent pending technology created via BioCers’ Polysacchidaride Ultra-hydrophilic Resorbable Engineering (PURE) process.
HaemoCer™ APH incorporates a sophisticated, plant-based polymer crosslinking that creates ultra-hydrophilic, biocompatible particles. Upon contact with blood HaemoCer™ enhances the natural clotting cascade by rapidly dehydrating the blood and accelerating the concentration of platelets, red blood cells and coagulation proteins at the bleeding site. HaemoCer™ also on blood interaction rapidly produces a gelled matrix that adheres to and forms a mechanical barrier with the bleeding tissue.
Phone: +49 921 787770-0
Fax: +49 921 787770-79
Get in contact with German companies in 3 easy steps! With one single question you can reach all relevant German Pavilion exhibitors of your selected industrial branch.
Click here if you notice an image that violates copyright or privacy rights.